Search

The present study focuses on the biosynthesis of gold nanoparticles (AuNPs) using Streptomyces coelicoflavus (S. coelicoflavus) SRBVIT13 isolated from marine salt pan soils collected from Ongole, Andhra Pradesh, India. The biosynthesised AuNPs are characterised by UV–visible spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy, high-resolution transmission electron microscopy and energy-dispersive X-ray analysis. Transmission electron microscopy study suggests that the biosynthesised AuNPs are spherical in shape within a size range of 12–20 nm (mean diameter as 14 nm). The anti-type II diabetes activity of AuNPs is carried out by testing it in vitro α-glucosidase and α-amylase enzyme inhibition activity and in vivo postprandial anti-hyperglycemic activity in sucrose and glucose-loaded streptozotocin induced diabetic albino Wister rats. AuNPs has shown a significant inhibitory activity of 84.70 and 87.82% with IC50 values of 67.65 and 65.59 μg/mL to α-glucosidase and α-amylase enzymes, while the diabetic rats have shown significant reduction in the post postprandial blood glucose level by 57.80 and 88.09%, respectively compared with control group after AuNPs treatment at the concentration of 300 and 600 mg/kg body weight. Hence, this biosynthesised AuNPs might be useful in combating type II diabetes mellitus for the betterment of human life.

The present study focuses on the biosynthesis of gold nanoparticles (AuNPs) using Streptomyces coelicoflavus (S. coelicoflavus) SRBVIT13 isolated from marine salt pan soils collected from Ongole, Andhra Pradesh, India. The biosynthesised AuNPs are characterised by UV–visible spectroscopy, X‐ray diffraction, Fourier transform infrared spectroscopy, high‐resolution transmission electron microscopy and energy‐dispersive X‐ray analysis. Transmission electron microscopy study suggests that the biosynthesised AuNPs are spherical in shape within a size range of 12–20 nm (mean diameter as 14 nm). The anti‐type II diabetes activity of AuNPs is carried out by testing it in vitro α ‐glucosidase and α ‐amylase enzyme inhibition activity and in vivo postprandial anti‐hyperglycemic activity in sucrose and glucose‐loaded streptozotocin induced diabetic albino Wister rats. AuNPs has shown a significant inhibitory activity of 84.70 and 87.82% with IC(50) values of 67.65 and 65.59 μg/mL to α ‐glucosidase and α ‐amylase enzymes, while the diabetic rats have shown significant reduction in the post postprandial blood glucose level by 57.80 and 88.09%, respectively compared with control group after AuNPs treatment at the concentration of 300 and 600 mg/kg body weight. Hence, this biosynthesised AuNPs might be useful in combating type II diabetes mellitus for the betterment of human life.

In the present work, we first report a low-cost, eco-friendly and simple procedure for biosynthesis of silver nanoparticles (Ag NPs) using plant fungus Puccinia graminis as reducing and capping agent. UV–vis spectroscopy, XRD, FTIR, FESEM and NC-AFM analyses were performed to confirm the formation of nanoparticles. Biologically synthesized Ag NPs showed UV peak at 427 nm with surface plasmon resonance found similar to silver. The FTIR spectra of Ag NPs exhibited prominent peaks at 3353, 2917, 2851, 1450.86, 1414.48, 946.20, 615.77 and 466.89 cm− 1. XRD patterns confirmed the formation of Ag NPs with face centered cubic structures. NC-AFM and FESEM images showed the formation of spherical, well dispersed Ag NPs in the size range of 30–120 nm, respectively.